ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Univ. of Chicago Hospital Apologizes For Overdose Death

June 23, 1995

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

“Do What’s Right for People With Cancer”. Glick’s Credo

May 24, 1996

Voluntary Organizations: ACS Board Approves Prostate Cancer Funding Set-Asides

November 15, 1996

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training

November 27, 1998